Book Text

2274

REFERENCES

1. Stock PG, Roland ME, Carlson L, et al: Kidney and liver transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study. Transplantation 76:370–375, 2003.

2. Fritsche L, Hoerstrup J, Budde K, et al: Kidney transplantation at the Charite: Long tradition, elderly patients and the duration of hospitalization. Clin Transpl 171–179, 2002.

3. Koch M, Banys P, Kanchana TP, et al: Methadone is a medication, not an addiction. Liver transplantation for patients on methadone maintenance. Liver Transpl 8:783–786, 2002.

4. Kanchana TP, Kaul V, Manzarbeitia C, et al: Liver transplantation for patients on methadone maintenance. Liver Transpl 8:778–782, 2002.

5. Ojo AO, Held PJ, Wolfe RA, et al: Trends in cadaveric organ donation in the United States: 1990–1999. Clin Transpl 105–109, 2002.

6. Port FK: Organ donation and transplantation trends in the United States, 2001. Am J Transplant 3(Suppl 4):7–12, 2003.

7. Metzger RA, Delmonico FL, Feng S, et al: Expanded criteria donors for kidney transplantation. Am J Transplant 3(Suppl 4):114–125, 2003.

8. Gridelli B, Remuzzi G: Strategies for making more organs available for transplantation. N Engl J Med 343:404–410, 2000.

9. Gregory GA, Caldwell CB: Anesthesia for transplantation. In Gregory GA (ed): Pediatric Anesthesia. New York, Churchill Livingstone, 2002, pp 541–566.

10. Jenkins DH, Reilly PM, Schwab CW: Improving the approach to organ donation: A review. World J Surg 23:644–649, 1999.

11. Park GR, Wilkins M, Higgins T, et al: Brain stem death and organ donation—11 years on defining death in non-heart beating organ donors. Br J Anaesth 91:577–579, 2003.

12. Kerridge IH, Saul P, Lowe M, et al: Death, dying and donation: Organ transplantation and the diagnosis of death. J Med Ethics 28(2):89–94, 2002.

13. Van Norman GA: A matter of life and death: What every anesthesiologist should know about the medical, legal, and ethical aspects of declaring brain death. Anesthesiology 91:275–287, 1999.

14. Rosenbaum SH: Ethical conflicts. Anesthesiology 91:3–4, 1999.

15. Taylor RM: Reexamining the definition and criteria of death. Semin Neurol 17:265–270, 1997.

16. Wijdicks EF: Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology 58:20–25, 2002.

17. A definition of irreversible coma: Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA 205:337–340, 1968.

18. Klintmalm GB, Marlon FL: Organ Procurement & Preservation. Austin, TX, Landes Bioscience, 1999.

19. White M, Wiechmann RJ, Roden RL, et al: Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 92:2183–2189, 1995.

20. Gelb AW, Robertson KM: Anaesthetic management of the brain dead for organ donation. Can J Anaesth 37:806–812, 1990.

21. Laskowski IA, Pratschke J, Wilhelm MJ, et al: Non-heartbeating kidney donors. Clin Transpl 13:281–286, 1999.

22. Nathan HM, Conrad SL, Held PJ, et al: Organ donation in the United States. Am J Transplant 3(Suppl 4):29–40, 2003.

23. Van Norman GA: Another matter of life and death: What every anesthesiologist should know about the ethical, legal, and policy implications of the non-heart-beating cadaver organ donor. Anesthesiology 98:763–773, 2003.

24. Weber M, Dindo D, Demartines N, et al: Kidney transplantation from donors without a heartbeat. N Engl J Med 347:248–255, 2002.

25. Brook NR, White SA, Waller JR, et al: Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 3:614–618, 2003.

26. Brook NR, Waller JR, Nicholson ML: Nonheart-beating kidney donation: Current practice and future developments. Kidney Int 63:1516–1529, 2003.

27. Southard JH, Belzer FO: Organ preservation. Annu Rev Med 46:235–247, 1995.

28. Muhlbacher F, Langer F, Mittermayer C: Preservation solutions for transplantation. Transplant Proc 31:2069–2070, 1999.

29. Wittwer T, Albes JM, Fehrenbach A, et al: Experimental lung preservation with Perfadex: Effect of the NO-donor nitroglycerin on postischemic outcome. J Thorac Cardiovasc Surg 125:1208–1216, 2003.

30. Matsumoto S, Kuroda Y: Perfluorocarbon for organ preservation before transplantation. Transplantation 74:1804–1809, 2002.

31. St Peter SD, Imber CJ, Friend PJ: Liver and kidney preservation by perfusion. Lancet 359:604–613, 2002.

32. Wight JP, Chilcott JB, Holmes MW, et al: Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: A rapid and systematic review. Clin Transpl 17:293–307, 2003.

33. Surman OS: The ethics of partial-liver donation. N Engl J Med 346:1038, 2002.

34. Kita Y, Aranami Y, Nomura Y, et al: Japanese organ transplant law: A historical perspective. Prog Transplant 10:106–108, 2000.

35. Chen CL, Fan ST, Lee SG, et al: Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 75(3 Suppl):S6–S11, 2003.

36. Abecassis M, Adams M, Adams P, et al: Consensus statement on the live organ donor. JAMA 284:2919–2926, 2000.

37. Trotter JF: Selection of donors for living donor liver transplantation. Liver Transpl 9(Suppl 2):S2–S7, 2003.

38. Shrestha R: Psychosocial assessment of adult living liver donors. Liver Transpl 9(10 Suppl 2):S8–S11, 2003.

39. Brown RS Jr, Russo MW, Lai M, et al: A survey of liver transplantation from living adult donors in the United States. N Engl J Med 348:818–825, 2003.

40. Busuttil RW: How safe are donors in adult-to-adult living related liver transplantation? Liver Transpl 8:121–122, 2002.

41. Trotter JF, Wachs M, Everson GT, et al: Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 346:1074–1082, 2002.

42. Russo MW, Brown RS Jr: Ethical issues in living donor liver transplantation. Curr Gastroenterol Rep 5:26–30, 2003.

43. Cronin DC 2nd, Millis JM, Siegler M: Transplantation of liver grafts from living donors into adults—too much, too soon. N Engl J Med 344:1633–1637, 2001.

44. Russo MW, Brown RS Jr: Financial impact of adult living donation. Liver Transpl 9(10 Suppl 2):S12–S15, 2003.

45. Isotani S, Fujisawa M, Ichikawa Y, et al: Quality of life of living kidney donors: The short-form 36-item health questionnaire survey. Urology 60:588–592, discussion 592, 2002.

46. Ratner LE, Montgomery RA, Kavoussi LR: Laparoscopic live donor nephrectomy. A review of the first 5 years. Urol Clin North Am 28:708–719, 2001.

47. Lee BR, Chow GK, Ratner LE, et al: Laparoscopic live donor nephrectomy: Outcomes equivalent to open surgery. J Endourol 14:811–819, discussion 819–820, 2000.

48. Matas AJ, Bartlett ST, Leichtman AB, et al: Morbidity and mortality after living kidney donation, 1999–2001: Survey of United States transplant centers. Am J Transplant 3:830–834, 2003.

49. Ellison MD, McBride MA, Taranto SE, et al: Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 74:1349–1351, 2002.

50. Ratner LE, Smith P, Montgomery RA, et al: Laparoscopic live donor nephrectomy: Pre-operative assessment of technical difficulty. Clin Transpl 14(Pt 2):427–432, 2000.

51. Buell JF, Hanaway MJ, Potter SR, et al: Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy. Am J Transplant 2:983–988, 2002.

2275

52. Samstein B, Emond J: Liver transplants from living related donors. Annu Rev Med 52:147–160, 2001.

53. Urata K, Kawasaki S, Matsunami H, et al: Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21:1317–1321, 1995.

54. Pomfret EA, Pomposelli JJ, Jenkins RL: Live donor liver transplantation. J Hepatol 34:613–624, 2001.

55. Pomfret EA, Pomposelli JJ, Lewis WD, et al: Live donor adult liver transplantation using right lobe grafts: Donor evaluation and surgical outcome. Arch Surg 136:425–433, 2001.

56. Marcos A, Fisher RA, Ham JM, et al: Right lobe living donor liver transplantation. Transplantation 68:798–803, 1999.

57. Marcos A, Fisher RA, Ham JM, et al: Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 69:1375–1379, 2000.

58. Pomfret EA: Early and late complications in the right-lobe adult living donor. Liver Transpl 9(10 Suppl 2):S45–S49, 2003.

59. Niemann CU, Roberts JP, Ascher NL, et al: Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl 8:1126–1132, 2002.

60. Testa G, Malago M, Nadalin S, et al: Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl 8:340–346, 2002.

61. Liu CL, Fan ST, Lo CM, et al: Living-donor liver transplantation for high-urgency situations. Transplantation 75(3 Suppl):S33–S36, 2003.

62. Marino IR, Doyle HR: Living donor in urgent cases: Ethical hazard? Liver Transpl 8:859–860, 2002.

63. Kam I: Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: Too little, too late. Liver Transpl 8:347–349, 2002.

64. Gaston RS, Danovitch GM, Adams PL, et al: The report of a national conference on the wait list for kidney transplantation. Am J Transplant 3:775–785, 2003.

65. Beavers KL, Sandler RS, Shrestha R: Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: A systematic review. Liver Transpl 8:110–117, 2002.

66. Miller CM: Regulation and oversight of adult living donor liver transplantation. Liver Transpl 9(10 Suppl 2):S69–S72, 2003.

67. Caplan AL: Proceed with caution: Live living donation of lobes of liver for transplantation. Liver Transpl 7:494–495, 2001.

68. Choudhry DK, Schwartz RE, Stayer SA, et al: Anesthetic management of living liver donors. Can J Anaesth 46:788–791, 1999.

69. Beebe DS, Carr R, Komanduri V, et al: Living liver donor surgery: Report of initial anesthesia experience. J Clin Anesth 12:157–161, 2000.

70. Adachi T: Anesthetic principles in living-donor liver transplantation at Kyoto University Hospital: Experiences of 760 cases. J Anesth 17:116–124, 2003.

71. Melendez JA, Arslan V, Fischer ME, et al: Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187:620–625, 1998.

72. Lutz JT, Valentin-Gamazo C, Gorlinger K, et al: Blood-transfusion requirements and blood salvage in donors undergoing right hepatectomy for living related liver transplantation. Anesth Analg 96:351–355, 2003.

73. Bowdish ME, Barr ML, Starnes VA: Living lobar transplantation. Chest Surg Clin N Am 13:505–524, 2003.

74. Aigner C, Seebacher G, Klepetko W: Lung transplantation. Donor selection. Chest Surg Clin N Am 13:429–442, 2003.

75. Battafarano RJ, Anderson RC, Meyers BF, et al: Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 120:909–915, 2000.

76. Barr ML, Baker CJ, Schenkel FA, et al: Living donor lung transplantation: Selection, technique, and outcome. Transplant Proc 33:3527–3532, 2001.

77. Cohen RG, Starnes VA: Living donor lung transplantation. World J Surg 25:244–250, 2001.

78. Vandam LD, Harrison JH, Murray JE, et al: Anesthetic aspects of renal homotransplantation in man. Anesthesiology 23:783–792, 1962.

79. de Lemos JA, Hillis LD: Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 7:2044–2054, 1996.

80. Groth CG: Presidential address 2002: Organ transplantation as a patient service worldwide. Transplantation 75:1098–1100, 2003.

81. Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730, 1999.

82. Gaston RS, Alveranga DY, Becker BN, et al: Kidney and pancreas transplantation. Am J Transplant 3(Suppl 4):64–77, 2003.

83. Gallon LG, Leventhal JR, Kaufman DB: Pretransplant evaluation of renal transplant candidates. Semin Nephrol 22:515–525, 2002.

84. Rigatto C: Clinical epidemiology of cardiac disease in renal transplant recipients. Semin Dial 16:106–110, 2003.

85. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186–192, 1995.

86. Ansari A, Kaupke CJ, Vaziri ND, et al: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 16:31–36, 1993.

87. Cho WH, Kim HT, Park CH, et al: Renal transplantation in advanced cardiac failure patients. Transplant Proc 29:236–238, 1997.

88. Rapoport J, Aviram M, Chaimovitz C, et al: Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. N Engl J Med 299:1326–1329, 1978.

89. Goldberg IJ: Lipoprotein metabolism in normal and uremic patients. Am J Kidney Dis 21:87–90, 1993.

90. Reissell E, Taskinen MR, Orko R, et al: Increased volume of gastric contents in diabetic patients undergoing renal transplantation: Lack of effect with cisapride. Acta Anaesthesiol Scand 36:736–740, 1992.

91. Eschbach JW, Kelly MR, Haley NR, et al: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321:158–163, 1989.

92. Marsh JT, Brown WS, Wolcott D, et al: rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39:155–163, 1991.

93. Lundin AP, Akerman MJ, Chesler RM, et al: Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 58:315–319, 1991.

94. Horowitz HI, Stein IM, Cohen BD, et al: Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med 49:336–345, 1970.

95. Pivalizza EG, Abramson DC, Harvey A: Perioperative hypercoagulability in uremic patients: A viscoelastic study. J Clin Anesth 9:442–445, 1997.

96. Ando M, Iwata A, Ozeki Y, et al: Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int 62:1757–1763, 2002.

97. Schmidt A, Stefenelli T, Schuster E, et al: Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37:56–63, 2001.

98. Herzog CA, Marwick TH, Pheley AM, et al: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33:1080–1090, 1999.

99. Grayburn PA, Hillis LD: Cardiac events in patients undergoing noncardiac surgery: Shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 138:506–511, 2003.

2276

100. Lee TH, Marcantonio ER, Mangione CM, et al: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049, 1999.

101. Norio K, Makisalo H, Isoniemi H, et al: Are diabetic patients in danger at renal transplantation? An invasive perioperative study. Eur J Anaesthesiol 17:729–736, 2000.

102. Peterson P, Hayes TE, Arkin CF, et al: The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 133:134–139, 1998.

103. Linke CL, Merin RG: A regional anesthetic approach for renal transplantation. Anesth Analg 55:69–73, 1976.

104. Akpek E, Kayhan Z, Kaya H, et al: Epidural anesthesia for renal transplantation: A preliminary report. Transplant Proc 31:3149–3150, 1999.

105. Kirvela M, Yli-Hankala A, Lindgren L: Comparison of propofol/alfentanil anaesthesia with isoflurane/N₂ O/fentanyl anaesthesia for renal transplantation. Acta Anaesthesiol Scand 38:662–666, 1994.

106. Heino A, Orko R, Rosenberg PH: Anaesthesiological complications in renal transplantation: A retrospective study of 500 transplantations. Acta Anaesthesiol Scand 30:574–580, 1986.

107. Dawidson I, Berglin E, Brynger H, et al: Intravascular volumes and colloid dynamics in relation to fluid management in living related kidney donors and recipients. Crit Care Med 15:631–636, 1987.

108. Carlier M, Squifflet JP, Pirson Y, et al: Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation 34:201–204, 1982.

109. Kirvela M, Olkkola KT, Rosenberg PH, et al: Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. Br J Anaesth 68:178–182, 1992.

110. Goyal P, Puri GD, Pandey CK, et al: Evaluation of induction doses of propofol: Comparison between endstage renal disease and normal renal function patients. Anaesth Intensive Care 30:584–587, 2002.

111. Thapa S, Brull SJ: Succinylcholine-induced hyperkalemia in patients with renal failure: An old question revisited. Anesth Analg 91:237–241, 2000.

112. Ryan DW: Preoperative serum cholinesterase concentration in chronic renal failure. Clinical experience of suxamethonium in 81 patients undergoing renal transplant. Br J Anaesth 49:945–949, 1977.

113. Powell DR, Miller R: The effect of repeated doses of succinylcholine on serum potassium in patients with renal failure. Anesth Analg 54:746–748, 1975.

114. Sakamoto H, Takita K, Kemmotsu O, et al: Increased sensitivity to vecuronium and prolonged duration of its action in patients with end-stage renal failure. J Clin Anesth 13:193–197, 2001.

115. Ebert TJ, Messana LD, Uhrich TD, et al: Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers. Anesth Analg 86:662–667, 1998.

116. Ebert TJ, Frink EJ Jr, Kharasch ED: Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 88:601–610, 1998.

117. Eger EI 2nd, Koblin DD, Bowland T, et al: Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 84:160–168, 1997.

118. Eger EI 2nd, Gong D, Koblin DD, et al: Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 85:1154–1163, 1997.

119. Frink EJ Jr, Malan TP Jr, Isner RJ, et al: Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 80:1019–1025, 1994.

120. Frink EJ Jr, Isner RJ, Malan TP Jr, et al: Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia. J Clin Anesth 6:239–242, 1994.

121. Munday IT, Stoddart PA, Jones RM, et al: Serum flouride concentration and urine osmolality after enflurane and sevoflurane anesthesia in male volunteers. Anesth Analg 81:353–359, 1995.

122. Artru AA: Renal effects of sevoflurane during conditions of possible increased risk. J Clin Anesth 10:531–538, 1998.

123. Conzen PF, Nuscheler M, Melotte A, et al: Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 81:569–575, 1995.

124. Nishimori A, Tanaka K, Ueno K, et al: Effects of sevoflurane anaesthesia on renal function. J Int Med Res 25:87–91, 1997.

125. Tsukamoto N, Hirabayashi Y, Shimizu R, et al: The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function. Anesth Analg 82:909–913, 1996.

126. Sear JW: Sufentanil disposition in patients undergoing renal transplantation: Influence of choice of kinetic model. Br J Anaesth 63:60–67, 1989.

127. Kirvela M, Lindgren L, Seppala T, et al: The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. J Clin Anesth 8:13–18, 1996.

128. Angst MS, Buhrer M, Lotsch J: Insidious intoxication after morphine treatment in renal failure: Delayed onset of morphine-6-glucuronide action. Anesthesiology 92:1473–1476, 2000.

129. Fyman PN, Reynolds JR, Moser F, et al: Pharmacokinetics of sufentanil in patients undergoing renal transplantation. Can J Anaesth 35(Pt 1):312–315, 1988.

130. Michelsen LG, Hug CC Jr: The pharmacokinetics of remifentanil. J Clin Anesth 8:679–682, 1996.

131. Hoke JF, Cunningham F, James MK, et al: Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther 281:226–232, 1997.

132. Morita K, Seki T, Nonomura K, et al: Changes in renal blood flow in response to sympathomimetics in the rat transplanted and denervated kidney. Int J Urol 6:24–32, 1999.

133. Gabriels G, August C, Grisk O, et al: Impact of renal transplantation on small vessel reactivity. Transplantation 75:689–697, 2003.

134. Heffron TG, Gadowski G, Buckingham F, et al: Laser Doppler blood flow measurement as a predictor of viability of renal allografts. Curr Surg 47:431–432, 1990.

135. Koning OH, Ploeg RJ, van Bockel JH, et al: Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 63:1620–1628, 1997.

136. Grundmann R, Kindler J, Meider G, et al: Dopamine treatment of human cadaver kidney graft recipients: A prospectively randomized trial. Klin Wochenschr 60:193–197, 1982.

137. Carmellini M, Romagnoli J, Giulianotti PC, et al: Dopamine lowers the incidence of delayed graft function in transplanted kidney patients treated with cyclosporine A. Transplant Proc 26:2626–2629, 1994.

138. Kadieva VS, Friedman L, Margolius LP, et al: The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth Analg 76:362–365, 1993.

139. Sandberg J, Tyden G, Groth CG: Low-dose dopamine infusion following cadaveric renal transplantation: No effect on the incidence of ATN. Transplant Proc 24:357, 1992.

140. Spicer ST, Gruenewald S, O'Connell PJ, et al: Low-dose dopamine after kidney transplantation: Assessment by Doppler ultrasound. Clin Transpl 13:479–483, 1999.

141. Kogan A, Singer P, Cohen J, et al: Readmission to an intensive care unit following liver and kidney transplantation: A 50-month study. Transplant Proc 31:1892–1893, 1999.

142. Lazowski T: The influence of the type of anaesthesia on postoperative pain after kidney transplantation. Ann Transplant 5:28–29, 2000.

2277

143. Knowles P, Hancox D, Letheren M, et al: An evaluation of intercostal nerve blockade for analgesia following renal transplantation. Eur J Anaesthesiol 15:457–461, 1998.

144. Gill JS, Tonelli M, Mix CH, et al: The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 14:1636–1642, 2003.

145. Ponticelli C, Villa M: Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant 17(Suppl 1):41–46, 2002.

146. Legendre C, Campistol JM, Squifflet JP, et al: Cardiovascular risk factors of sirolimus compared with cyclosporine: Early experience from two randomized trials in renal transplantation. Transplant Proc 35(3 Suppl):S151–S153, 2003.

147. Gruessner RW, Bartlett ST, Burke GW, et al: Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. Clin Transpl 12:260–262, 1998.

148. Reddy KS, Stablein D, Taranto S, et al: Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 41:464–470, 2003.

149. Kirvela M, Salmela K, Toivonen L, et al: Heart rate variability in diabetic and non-diabetic renal transplant patients. Acta Anaesthesiol Scand 40:804–808, 1996.

150. Oppert M, Schneider U, Bocksch W, et al: Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantation. Transplant Proc 34:2251–2252, 2002.